One of the ways to use market intelligence to analyze trends within the mesenchymal stem cell (MSC) market is to assess how the cell type is being discussed on leading social media platforms, such as Twitter.
Twitter.com is one of the most widely used social media platforms today. It has with 316 million monthly active users and 500 million Tweets sent per day, according to Twitter’s company statistics.
It is also the 9th most visited website in the world, an impressive accomplishment.
Social Analytics Reveal Key Trends about Mesenchymal Stem Cell (MSC) Research
The figure below shows a hashtag map for the term “#mesenchymal.” It was produced using the social analytics platform Hashtagify.me.
The linked topics shown as spokes in this figure represent the top hashtags that are used together with the hashtag “#mesenchymal” on Twitter.
In the hashtag map below, topics that frequently used along with the term “mesenchymal” on Twitter are shown in large bubbles, while topics that are less frequently used along with the term “mesenchymal” appear in in smaller bubbles.
The key finding is that nearly all of the terms frequently associated with “mesenchymal” on Twitter are related to therapeutic applications, for example:
- Stem cells
- Regenerative medicine
FIGURE: Top 10 Hashtags Related to the Term “Mesenchymal” on Twitter
Top 10 Hashtags Related to “Mesenchymal” on Twitter
Next, the relative search volume and popularity of each of these “mesenchymal” related hashtags is shown in the table below.
It is a tabular representation of the same data set presented in the previous hashtag map, but with additional detail provided. Click to enlarge it to see the data clearly.
TABLE:Top 10 Hashtags Related to “#Mesenchymal” on Twitter
BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.
To learn more, view the global strategic report “Mesenchymal Stem Cells – Advances & Applications.”